(1 - 27 from 41
)
Firm wins grant for fast way to make DNA vaccines - CIDRAPwww.cidrap.umn.edu › news-perspective › › firm-wins-grant-fast-...
www.cidrap.umn.edu
Vical President Vijay Samant said the company's RapidResponse system is designed to allow fast, large-scale production of DNA vaccines at low cost and is ...
Injecting a Dose of Energy Into a Vaccine Company - PharmaVoicewww.pharmavoice.com › news › injecting-a-dose-of-energy-into-...
www.pharmavoice.com
Vijay Samant runs on pure energy, and it's paying dividends. The dynamic president and CEO of Vical Inc. has made a habit of success, thanks in part to his ...
News | Astellas Pharma Inc.www.astellas.com › news
www.astellas.com
20 Sept — ... which we expect to obtain during the fourth quarter of 2017,” said Vijay Samant, President and Chief Executive Officer, Vical.
Vical's cancer immunotherapy fails in late-stage trial - PMLiVEwww.pmlive.com › pharma_news › vicals_cancer_immunotherapy_fails_i...
www.pmlive.com
13 Aug — ... efficacy endpoints, even though we believe it was well-designed and well-executed," said Vijay Samant, president and CEO of Vical.
sorted by relevance / date